A 45-year-old man with a known diagnosis of multiple myeloma experiences sudden onset of severe shortness of breath, wheezing, urticaria, and hypotension during a platelet transfusion. He has had multiple prior transfusions without any adverse events. What is the most probable cause of this transfusion reaction?
সমাধান
সঠিক উত্তর: Option A
- In this clinical scenario, a 45-year-old man with multiple myeloma develops sudden severe shortness of breath, wheezing, urticaria, and hypotension during a platelet transfusion.
- Despite multiple prior transfusions without problems, these acute symptoms strongly suggest a severe allergic or anaphylactic transfusion reaction.
- The sudden onset of respiratory symptoms (severe shortness of breath, wheezing) combined with urticaria (hives) and hypotension indicates a classic presentation of an anaphylactic reaction.
- Anaphylactic transfusion reactions are typically caused by the recipient’s antibodies reacting to donor plasma proteins. The most common cause is IgA deficiency in the recipient, who produces anti-IgA antibodies that react with IgA present in the transfused blood components.
- This patient’s multiple prior uneventful transfusions do not exclude anaphylaxis now, as sensitization to IgA antigens may develop over time or the level of anti-IgA antibodies can fluctuate.
Other transfusion reactions can be considered but are less likely:
- Febrile non-hemolytic transfusion reaction (FNHTR) usually presents with mild fever and chills, not hypotension or respiratory distress.
- Transfusion-related acute lung injury (TRALI) causes respiratory distress but typically does not cause urticaria or hypotension, and presents with non-cardiogenic pulmonary edema.
- Acute hemolytic transfusion reaction due to ABO incompatibility usually involves fever, flank pain, hemoglobinuria, and signs of hemolysis rather than wheezing and urticaria.
Important points to note:
- Anaphylactic reactions typically occur within minutes of starting transfusion and involve IgE-mediated hypersensitivity.
- IgA-deficient patients with anti-IgA antibodies are at high risk for severe anaphylaxis.
- Treatment involves immediate cessation of transfusion, supportive care with epinephrine, antihistamines, and corticosteroids.
- Future transfusions for IgA-deficient patients require use of washed red blood cells or plasma-depleted components.
Reference: Hoffbrand, A. V., Moss, P. A. H. *Essential Haematology*, 7th Edition, Chapter 14: Transfusion Reactions & Blood Group Immunology, Pg 210-215.
- Despite multiple prior transfusions without problems, these acute symptoms strongly suggest a severe allergic or anaphylactic transfusion reaction.
- The sudden onset of respiratory symptoms (severe shortness of breath, wheezing) combined with urticaria (hives) and hypotension indicates a classic presentation of an anaphylactic reaction.
- Anaphylactic transfusion reactions are typically caused by the recipient’s antibodies reacting to donor plasma proteins. The most common cause is IgA deficiency in the recipient, who produces anti-IgA antibodies that react with IgA present in the transfused blood components.
- This patient’s multiple prior uneventful transfusions do not exclude anaphylaxis now, as sensitization to IgA antigens may develop over time or the level of anti-IgA antibodies can fluctuate.
Other transfusion reactions can be considered but are less likely:
- Febrile non-hemolytic transfusion reaction (FNHTR) usually presents with mild fever and chills, not hypotension or respiratory distress.
- Transfusion-related acute lung injury (TRALI) causes respiratory distress but typically does not cause urticaria or hypotension, and presents with non-cardiogenic pulmonary edema.
- Acute hemolytic transfusion reaction due to ABO incompatibility usually involves fever, flank pain, hemoglobinuria, and signs of hemolysis rather than wheezing and urticaria.
Important points to note:
- Anaphylactic reactions typically occur within minutes of starting transfusion and involve IgE-mediated hypersensitivity.
- IgA-deficient patients with anti-IgA antibodies are at high risk for severe anaphylaxis.
- Treatment involves immediate cessation of transfusion, supportive care with epinephrine, antihistamines, and corticosteroids.
- Future transfusions for IgA-deficient patients require use of washed red blood cells or plasma-depleted components.
Reference: Hoffbrand, A. V., Moss, P. A. H. *Essential Haematology*, 7th Edition, Chapter 14: Transfusion Reactions & Blood Group Immunology, Pg 210-215.